Prognostic significance of dicer cellular levels in soft tissue sarcomas

Cancer Investigation

Volumn 30, Issue 2, 2012, Pages 172-179

  Papachristou, Dionysios J ^a,b,c   Rao, Uma N M ^b   Korpetinou, Angeliki ^a,c   Giannopoulou, Efstathia ^c   Sklirou, Emilia ^a,c   Kontogeorgakos, Vasileios ^d   Kalofonos, Haralabos P ^c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PATRAS   (Greece)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dicer; Prognosis; Soft tissue tumors; Tissue microarray

Indexed keywords

DICER;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CELL LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MIDDLE AGED; PROGNOSIS; RIBONUCLEASE III; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 84856101636     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.633293     Document Type: Article

References (31)

1. Fletcher CDM, Rydholm A, Singer S, Sundaram M, Coindre JM. Soft Tissue Tumors: Epidemiology, Clinical Features, Histopathological Typing andGrading. Lyon, France: IARCPress, 2002.
2. ClarkMA, Fisher C, Judson I, Thomas JM. Soft tissue sarcomas in adults. N Eng J Med 2005;353:701-711.
3. Olsen RJ, Tarantolo SR,Hinrichs SH.Molecular approaches to sarcoma therapy. Sarcoma 2002;6:27-42. (Pubitemid 34620886)
4. Coindre JM, TrojaniM, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcomas. Cancer 1986;58:306-309. (Pubitemid 16058606)
5. Verweij J, Baker LH. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations. Eur J Cancer 2010;46:863-868.
6. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009;136:642-645.
7. Ambros V. The functions of animal microRNAs. Nature 2009;431:343-349.
8. Drakaki A, Iliopoulos D. MicroRNA gene networks in oncogenesis. Curr Genomics 2009;10:35-41.
9. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509-3512. (Pubitemid 40616320)
10. Croce CM, Calin GA. MicroRNAs, cancer, and stem cell division. Cell 2005;122:6-7. (Pubitemid 40977933)
11. Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 2011;47:1127-1137.
12. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007;67:2345-2350. (Pubitemid 46424256)
13. GrelierG, VoirinN, AyAS,CoxDG,Chabaud S, Treilleux I,Ĺeon- Goddard S, Rimokh R, Mikaelian I, Venoux C, Puisieux A, Lasset C,Moyret-Lalle C. Prognostic value ofDicer in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009;101:673-683.
14. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, DeaversMT,Mourad-ZeidanA,WangH,Mueller P, LenburgME, Gray JW,Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar- Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008;359:2641-2650.
15. Flavin RJ, Smyth PC, Finn SR, Laios A, O'Toole SA, Barrett C, Ring M, Denning KM, Li J, Aherne ST, Aziz NA, Alhadi A, Sheppard BL, Loda M, Martin C, Sheils OM, O'Leary JJ. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod Pathol 2008;21:676-684. (Pubitemid 351744832)
16. Chiosea S, Jelezcova E, Chandran U, Acquafondata M,McHale T, Sobol RW, Dhir R. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006;169:1812-1820. (Pubitemid 351182010)
17. Chiosea SI, Barnes EL, Lai SY, Egloff AM, Sargent RL, Hunt JL, Seethala, RR. Mucoepidermoid carcinoma of upper aerodigestive tract: Clinicopathologic study of 78 cases with immunohistochemical analysis of dicer expression. Virchows Arch 2008;452:629-635.
18. Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, Gamble J, Tran N. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009;124:2855-2863.
19. Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011;47:1414-1419.
20. Papachristou DJ, Korpetinou A, Giannopoulou E, Antonacopoulou AG, Papadaki H, Grivas P, Scopa CD, Kalofonos HP. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 2011;459:431-440.
21. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumorMARKer prognostic studies (REMARK). Nat Clin Pract Urol 2005;2:416-422. (Pubitemid 43115010)
22. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, deMascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft tissue sarcomas of adults; study of pathological prognostic variables and definition of histopathological grading system. Int J Cancer 1984;33:37-42. (Pubitemid 14223231)
23. Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: The challenge of providing precise information in an imprecise world. Histopathology 2006;48:42-50.
24. Rao UN, Finkelstein SD, Jones MW. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol 1999;12:1001-1009.
25. Ren B, Yu YP, Jing L, Liu L,Michalopoulos GK, Luo JH, Rao UN. Gene expression analysis of human soft tissue leiomyosarcomas. Hum Pathol 2003;34:449-458.
26. Masciullo V, Berardengo E, Boglione A, Sgambato A, Bernardi A, ForniM, LinariA, Cito L, Scambia G, Comandone A,Giordano A. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas. Clin Cancer Res 2008;14:4775-4779.
27. Tomita Y, Morooka T, Hoshiba Y, Zhang B, Qiu Y, Nakamichi I, Hamada K, Ueda T, Naka N, Kudawara I, Aozasa K. Prognostic significance of activated AKT expression in soft-tissue sarcoma. Clin Cancer Res 2006;12:3070-3077. (Pubitemid 43837353)
28. Papachrtistou DJ,Gkretsi V, Tu Y, Shi X, Chen K, Larjava H, Rao UN, Wu C. Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcoma. Histopathology 2007;51:499-508. (Pubitemid 47437823)
29. Steigen SE, Schaefer DF, West RB, Nielsen TO. Expression of insulin-like growth Factor 2 in mesenchymal neoplasms. Mod Pathol 2009;22:914-921.
30. Ahrens WA, Ridenour RVR, III, Caron BL, Miller DV, Folpe AL. GLUT-1 expression in mesenchymal tumors: An immunohistochemical study of 247 soft tissue and bone neoplasms.HumPathol 2008;39:1519-1526.
31. Mikuma T, Kawasaki H, Yamamoto Y, Taira K. Overexpression of Dicer enhances RNAi-mediate gene silencing by short-hairpin RNAs (shRNAs) in human cells. Nucleic Acids Symp Ser (Oxf) 2004;48:191-192.